Xultophy

Drug Novo Nordisk Inc
Total Payments
$79,670
Transactions
340
Doctors
340
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2017 $79,670 340 340

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $79,670 340 100.0%

Top Doctors Receiving Payments for Xultophy — Page 3

Doctor Specialty Location Total Records
, MD Endocrinology, Diabetes & Metabolism Cleveland, OH $260.00 1
, M.D Endocrinology, Diabetes & Metabolism Houston, TX $260.00 1
, MD Endocrinology, Diabetes & Metabolism Boulder, CO $260.00 1
, MD Endocrinology, Diabetes & Metabolism Santa Barbara, CA $260.00 1
, MD Endocrinology, Diabetes & Metabolism Branford, CT $260.00 1
, M.D Endocrinology, Diabetes & Metabolism Atlanta, GA $260.00 1
, M.D Internal Medicine Dallas, TX $260.00 1
, M.D Endocrinology, Diabetes & Metabolism Flint, MI $260.00 1
, M. D Endocrinology, Diabetes & Metabolism Henderson, NV $260.00 1
, M.D Endocrinology, Diabetes & Metabolism Greenville, NC $260.00 1
, MD Specialist Edison, NJ $260.00 1
, MD Cardiovascular Disease Bridgeport, CT $260.00 1
, M.D Internal Medicine Fullerton, CA $260.00 1
, MD Endocrinology, Diabetes & Metabolism Clinton, NJ $260.00 1
, M.D Endocrinology, Diabetes & Metabolism Dallas, TX $260.00 1
, M.D Internal Medicine Jefferson City, MO $260.00 1
, MD Endocrinology, Diabetes & Metabolism Reno, NV $260.00 1
, MD Endocrinology, Diabetes & Metabolism Portland, OR $260.00 1
, M.D Endocrinology, Diabetes & Metabolism Bedford, NH $260.00 1
, MD Endocrinology, Diabetes & Metabolism Bronx, NY $260.00 1
, MD Endocrinology, Diabetes & Metabolism Chicago, IL $260.00 1
, M.D Endocrinology, Diabetes & Metabolism Lawrenceville, GA $260.00 1
, MD Endocrinology, Diabetes & Metabolism Denver, CO $260.00 1
, DO Endocrinology, Diabetes & Metabolism Corvallis, OR $260.00 1
, MD Endocrinology, Diabetes & Metabolism Port Charlotte, FL $260.00 1

About Xultophy

Xultophy is a drug associated with $79,670 in payments to 340 healthcare providers, recorded across 340 transactions in the CMS Open Payments database. The primary manufacturer is Novo Nordisk Inc.

Payment data is available from 2017 to 2017. In 2017, $79,670 was paid across 340 transactions to 340 doctors.

The most common payment nature for Xultophy is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($79,670, 100.0% of total).